Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Viral Clearance: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Viral Clearance Market to Reach $1.8 Billion by 2030
The global market for Viral Clearance estimated at US$474.5 Million in the year 2022, is projected to reach a revised size of US$1.8 Billion by 2030, growing at a CAGR of 18.4% over the analysis period 2022-2030.
There is an 8-year perspective that provides insights into the percentage breakdown of value sales for the years 2023 and 2030 for viral clearance and other segments in the pharmaceutical and biotechnology industry. These segments encompass recombinant proteins, blood and blood products, vaccines, other applications, contract research organizations (CROs), academic research institutes, and other end-uses. Moreover, there's an analysis of the viral clearance market's annual sales from 2014 to 2030.
Recombinant Proteins, one of the segments analyzed in the report, is projected to record 18.7% CAGR and reach US$430.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Blood and Blood Products segment is readjusted to a revised 16.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $146.8 Million, While China is Forecast to Grow at 18% CAGR
The Viral Clearance market in the U.S. is estimated at US$146.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$319.2 Million by the year 2030 trailing a CAGR of 18% over the analysis period 2022 to 2030.
This information comprises a detailed analysis of various segments within the global viral clearance market. It includes data on annual sales from 2022 to 2030 in US$ Thousand and corresponding percentage CAGR for different geographic regions, such as the USA, Canada, Japan, China, Europe, Asia-Pacific, and the Rest of the World.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.1% and 15.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $474.5 Million |
| Forecasted Market Value (USD) by 2030 | $1800 Million |
| Compound Annual Growth Rate | 18.1% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Viral Clearance - Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
FOCUS ON SELECT PLAYERS (Total 41 Featured)
- Avance Biosciences Inc.
- BSL BIOSERVICE Scientific Laboratories Munich GmbH
- Charles River Laboratories International, Inc.
- Clean Cells Inc.
- Lonza Group AG
- Merck KgaA
- SGS SA
- Sigma-Aldrich Corporation
- Texcell, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/q4ld5f
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
